UA95917C2 - Композиция, содержащая донор no и дитиолан, и их применение для улучшения сексуальной функции - Google Patents

Композиция, содержащая донор no и дитиолан, и их применение для улучшения сексуальной функции

Info

Publication number
UA95917C2
UA95917C2 UAA200802671A UAA200802671A UA95917C2 UA 95917 C2 UA95917 C2 UA 95917C2 UA A200802671 A UAA200802671 A UA A200802671A UA A200802671 A UAA200802671 A UA A200802671A UA 95917 C2 UA95917 C2 UA 95917C2
Authority
UA
Ukraine
Prior art keywords
donor
dithiolane
compositions
improvement
sexual function
Prior art date
Application number
UAA200802671A
Other languages
English (en)
Ukrainian (uk)
Inventor
Клаус Вессель
Original Assignee
Энкрипта гмбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Энкрипта гмбХ filed Critical Энкрипта гмбХ
Publication of UA95917C2 publication Critical patent/UA95917C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Данное изобретение относится к твердым композициям, которые включают соединение, улучшающее доступность оксида азота (NO). Согласно изобретению пероральная композиция содержит L-аргинин и R-α-липоевую кислоту в эффективном количестве, где L-аргинин присутствует в молярном избытке относительно количества R-α-липоевой кислоты, присутствующей в композиции.
UAA200802671A 2005-08-04 2006-08-04 Композиция, содержащая донор no и дитиолан, и их применение для улучшения сексуальной функции UA95917C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107206A EP1754478B1 (en) 2005-08-04 2005-08-04 Liquid Composition comprising arginine and alpha-lipoic acid and its use for improvement of sexual function

Publications (1)

Publication Number Publication Date
UA95917C2 true UA95917C2 (ru) 2011-09-26

Family

ID=35502745

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200802671A UA95917C2 (ru) 2005-08-04 2006-08-04 Композиция, содержащая донор no и дитиолан, и их применение для улучшения сексуальной функции

Country Status (17)

Country Link
US (1) US9107889B2 (ru)
EP (2) EP1754478B1 (ru)
JP (3) JP5295766B2 (ru)
CN (2) CN102670591B (ru)
AT (1) ATE418976T1 (ru)
BR (1) BRPI0614434B8 (ru)
CY (2) CY1109430T1 (ru)
DE (1) DE602005012089D1 (ru)
DK (2) DK1754478T3 (ru)
ES (2) ES2320560T3 (ru)
MX (1) MX2008001554A (ru)
PL (2) PL1754478T3 (ru)
PT (2) PT1754478E (ru)
RU (1) RU2423120C2 (ru)
SI (2) SI1754478T1 (ru)
UA (1) UA95917C2 (ru)
WO (1) WO2007017191A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005012089D1 (de) * 2005-08-04 2009-02-12 Extarma Ag Flüssige Zusammensetzung enthaltend Arginine und alpha-Liponsäure zur Verbesserung der sexuellen Funktion
FR2939042B1 (fr) * 2008-11-28 2010-11-26 Oreal PROCEDE DE DEPIGMENTATION DES MATIERES KERATINIQUES A l'AIDE DE COMPOSES DITHIOLANNES.
RU2458537C1 (ru) * 2011-03-14 2012-08-20 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин
FR3012039A1 (fr) * 2013-10-22 2015-04-24 Philippe Olivier Gorny Medicament ou produit dietetique et son utilisation pour prevenir ou traiter les dysfonctionnements sexuels de l'homme et de la femme
DK180173B1 (en) * 2018-12-07 2020-07-14 Inxo Ivs Compositions for improving sexual function
US11571405B2 (en) 2018-12-07 2023-02-07 Inxo A/S Compositions for improving sexual function
CN109876194B (zh) * 2019-04-11 2021-04-02 湖北大学 一种可调节降解速率的poss-peg杂化水凝胶及其制备方法和其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364822D1 (en) 1982-03-15 1986-09-04 Ici Plc Process of oxidising hydrocarbons
DE3629116A1 (de) * 1986-08-27 1988-03-10 Asta Pharma Ag Verfahren zur herstellung enantiomerenreiner r-(+)-(alpha)-liponsaeure und s-(-)-(alpha)-liponsaeure (thioctsaeure) sowie nonen- beziehungsweise mesylderivate als zwischenprodukte hierfuer
DE3840076A1 (de) 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
EP0318891B1 (de) 1987-12-04 1992-01-02 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
PT95826B (pt) 1989-11-09 1997-11-28 Asta Medica Ag Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
DE4137773A1 (de) 1991-11-16 1993-05-19 Degussa Herstellung und verwendung von salzen der reinen enantiomere der (alpha)-liponsaeure
JP2684287B2 (ja) * 1991-12-20 1997-12-03 株式会社河合楽器製作所 楽器自動演奏装置
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
DE4317646A1 (de) 1993-05-27 1994-12-01 Asta Medica Ag Tabletten mit Thioctsäure und mindestens einer basischen Komponente
DE4433764A1 (de) 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
US6234176B1 (en) 1996-06-21 2001-05-22 Integrated Medical Systems, Inc. Data logger for transportable life support system
US7504376B2 (en) * 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
US6387645B1 (en) 1998-07-16 2002-05-14 Hyseq, Inc. Methods and materials relating to novel CD39-like polypeptides
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
US6207190B1 (en) * 1998-08-13 2001-03-27 Chronorx, Llc Dosage forms for the treatment of the chronic glaucomas
AR042572A1 (es) 1999-04-02 2005-06-29 Sod Conseils Rech Applic Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
FR2791571B1 (fr) 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
ES2162586B1 (es) 1999-11-25 2002-07-01 Moraleda Manuel Gomez Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
CZ20022927A3 (cs) 2000-02-01 2003-06-18 Muscletech Research And Development Inc. Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly
US6387945B2 (en) 2000-04-11 2002-05-14 The Regents Of The University Of California Lipoic acid analogs
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US7128930B1 (en) * 2000-09-01 2006-10-31 Meir S. Sacks Compositions and methods for treating sexual dysfunction
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
ITRM20010621A1 (it) 2001-10-18 2003-04-18 Aldo Fassi Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
WO2003084532A1 (en) 2002-04-03 2003-10-16 Avery Mitchell A Lipoic acid analogs useful as provitamins and antioxidants
NL1022153C2 (nl) * 2002-12-12 2004-06-15 Tno Cholesterol verlagend preparaat, voedingssupplement en voedingsmiddel en werkwijzen voor de bereiding daarvan.
DE602005012089D1 (de) * 2005-08-04 2009-02-12 Extarma Ag Flüssige Zusammensetzung enthaltend Arginine und alpha-Liponsäure zur Verbesserung der sexuellen Funktion

Also Published As

Publication number Publication date
WO2007017191A2 (en) 2007-02-15
CN102670591A (zh) 2012-09-19
CN102670591B (zh) 2014-08-06
BRPI0614434B1 (pt) 2020-04-28
DK1909782T3 (da) 2012-08-27
WO2007017191A3 (en) 2007-05-24
JP2009508810A (ja) 2009-03-05
ATE418976T1 (de) 2009-01-15
SI1754478T1 (sl) 2009-06-30
JP5925714B2 (ja) 2016-05-25
BRPI0614434B8 (pt) 2021-05-25
JP5295766B2 (ja) 2013-09-18
RU2008107877A (ru) 2009-09-10
CN101237862B (zh) 2012-03-21
US20080161381A1 (en) 2008-07-03
PT1909782E (pt) 2012-08-16
PT1754478E (pt) 2009-03-31
PL1754478T3 (pl) 2009-07-31
JP2016104738A (ja) 2016-06-09
EP1909782B1 (en) 2012-05-16
CY1109430T1 (el) 2014-08-13
US9107889B2 (en) 2015-08-18
MX2008001554A (es) 2008-04-22
ES2388074T3 (es) 2012-10-08
EP1754478A1 (en) 2007-02-21
DK1754478T3 (da) 2009-05-04
CY1113235T1 (el) 2016-04-13
DE602005012089D1 (de) 2009-02-12
ES2320560T3 (es) 2009-05-25
BRPI0614434A2 (pt) 2011-03-29
PL1909782T3 (pl) 2012-12-31
EP1909782A2 (en) 2008-04-16
RU2423120C2 (ru) 2011-07-10
JP2013136616A (ja) 2013-07-11
CN101237862A (zh) 2008-08-06
SI1909782T1 (sl) 2012-09-28
EP1754478B1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
MX338029B (es) Composiciones farmaceuticas topicas.
CY1113235T1 (el) Συνθεσεις περιλαμβανουσες αργινινη και r-α-λιποϊκο οξυ και χρηση αυτων για βελτιωση της σεξουαλικης λειτουργιας
EP3342840A3 (en) Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
MY148496A (en) Dpp iv inhibitor formulations
WO2012092528A8 (en) Treatment of erectile dysfunction and other indications
TW200637490A (en) Fertilizer-compatible composition
WO2008112164A3 (en) Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
WO2008073332A3 (en) Creatine compositions for skin treatment
CU20060153A7 (es) Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen
WO2009130616A3 (en) Improved tlr3 agonist compositions
WO2005086763A3 (en) Stable injectable compositions
UA100394C2 (en) Lipoic acid pellet composition
WO2009055084A3 (en) Vitamin c compositions
TW200718740A (en) Compositions effective to suppress void formation
WO2010011856A3 (en) Stereospecificity of methylsulfinyl reduction
WO2007035718A3 (en) Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
TW200505460A (en) Rosmarinic acid composition
WO2008005806A3 (en) Therapeutic methods, compositions, and compounds
WO2008068427A3 (fr) Composition terpénique anti-microorganisme
WO2009125236A3 (en) Modification of sperm motility and its storage shelf time
WO2007139948A3 (en) Imidazoazepinone compounds
WO2012004782A3 (en) Oral remedial mineral replenishment (omr) preparation
MX2010007632A (es) Composicion farmaceutica estable.
박찬임 Tasks for creating and fostering social enterprise
TH10686A3 (th) องค์ประกอบที่มีส่วนผสมของสารสกัดมะหาดและเพชรสังฆาตที่มีฤทธิ์ในการ กระตุ้นการเจริญเติบโตเซลล์กระดูก